Search Results - "Prado, Alejandro Ferraz"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    The role of matrix metalloproteinase-9 in cardiac remodeling and dysfunction and as a possible blood biomarker in heart failure by Rodrigues, Keuri Eleutério, Pontes, Maria Helena Barbosa, Cantão, Manoel Benedito Sousa, Prado, Alejandro Ferraz

    Published in Pharmacological research (01-08-2024)
    “…Heart failure (HF) is the leading cause of morbidity and mortality in cardiovascular diseases, being responsible for many hospitalizations annually. HF is…”
    Get full text
    Journal Article
  3. 3

    Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure by Gonçalves, Pricila Rodrigues, Nascimento, Lisandra Duarte, Gerlach, Raquel Fernanda, Rodrigues, Keuri Eleutério, Prado, Alejandro Ferraz

    Published in Pharmaceuticals (Basel, Switzerland) (25-07-2022)
    “…Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in cardiac output and an increase in intracardiac pressure at rest or…”
    Get full text
    Journal Article
  4. 4

    MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension by Ribeiro Vitorino, Thaís, Ferraz do Prado, Alejandro, Bruno de Assis Cau, Stefany, Rizzi, Elen

    Published in Biochemical pharmacology (01-09-2023)
    “…[Display omitted] Hypertension is one of the leading risk factors for the development of heart failure. Despite being a multifactorial disease, in recent…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta by Pernomian, Laena, do Prado, Alejandro Ferraz, Silva, Bruno Rodrigues, de Paula, Tiago Dal-Cin, Grando, Marcella Daruge, Bendhack, Lusiane Maria

    Published in Life sciences (1973) (01-05-2021)
    “…Hypertension underlies endothelial dysfunction, and activation of vasorelaxation signaling with low dependence on nitric oxide (NO) represents a good…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Relaxation induced by the nitric oxide donor and cyclooxygenase inhibitor NCX2121 in renal hypertensive rat aortas by de Paula, Tiago Dal-Cin, Silva, Bruno R., Grando, Marcella D., Pernomian, Laena, do Prado, Alejandro Ferraz, Bendhack, Lusiane Maria

    “…There is an imbalance between contractile and relaxing endothelial factors in hypertension which induces vascular dysfunction. It involves cyclooxygenase (COX)…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Use of a Recombinant Fluorescent MMP‐2 as a Reporter for Tracking the Involvement of This Protease in Target Organ Damage Found in Cardiovascular Diseases by do Prado, Alejandro Ferraz, Azevedo, Aline, Castro, Myrella Lessio, Gerlach, Raquel Fernanda

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Matrix Metalloproteinase 2 (MMP‐2) is elevated in hypertensive heart and vessel remodeling, being also highly expressed in organs that show…”
    Get full text
    Journal Article
  17. 17

    Matrix Metalloproteinase 2 (MMP‐2) Increases Atherosclerotic Aorta Rings Vasoconstriction by Azevedo, Aline, do Prado, Alejandro Ferraz, Pernomian, Laena, Bendhack, Lusiane Maria, Gerlach, Raquel Fernanda

    Published in The FASEB journal (01-04-2013)
    “…Abstract only The present study aimed to evaluate the vascular function of atherosclerotic aortic rings after intraluminal injection of MMP‐2. Thoracic aorta…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20